Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03525106 · ClinicalTrials.gov registry record · NA
Positive Psychology Intervention to Improve Quality of Life in Stem Cell Transplant Survivors and Their Caregivers
A NA study of Hematopoietic Cell Transplantation Recipient, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT03525106 is a NA study of Hematopoietic Cell Transplantation Recipient that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 29 participants, below the 1,296-participant average among 4 other Hematopoietic Cell Transplantation Recipient trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03525106, a NA study of Hematopoietic Cell Transplantation Recipient, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies a positive psychology intervention designed to improve quality of life in stem cell transplant survivors and their caregivers. Positive psychology (PP) uses systematic exercises (e.g., gratitude letters, acts of kindness) to potentially boost levels of optimism, resilience, and life enjoyment. PP interventions are often enjoyable, easy to understand, and can be delivered via telephone. PP intervention may improve the quality of life of participants who have undergone a stem cell transplant or their caregivers.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Survey Administration
- BEHAVIORAL Exercise Intervention
- BEHAVIORAL Telephone-Based Intervention
- BEHAVIORAL Booklet
Study Locations (1)
Washington
- Fred Hutch/University of Washington Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2018-05-18 |
| Est. Completion | 2020-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03525106
The ClinicalTrials.gov registry entry for NCT03525106 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,296-participant average among 4 other Hematopoietic Cell Transplantation Recipient trials with a reported enrollment target (98% lower). The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hematopoietic Cell Transplantation Recipient appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT03525106 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT03525106 about?
NCT03525106 is a clinical study titled "Positive Psychology Intervention to Improve Quality of Life in Stem Cell Transplant Survivors and Their Caregivers". This trial studies a positive psychology intervention designed to improve quality of life in stem cell transplant survivors and their caregivers. Positive psychology (PP) uses systematic exercises (e.g., gratitude letters, acts of kindness) to potentially boost levels of optimism, resilience, and li...
What is the current status of trial NCT03525106?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2018-05-18. Estimated completion is 2020-03-01.
What conditions does trial NCT03525106 study?
This clinical trial studies the following conditions: Hematopoietic Cell Transplantation Recipient.
What interventions are being tested in trial NCT03525106?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Survey Administration (OTHER), Exercise Intervention (BEHAVIORAL), Telephone-Based Intervention (BEHAVIORAL), Booklet (BEHAVIORAL).
Who is sponsoring clinical trial NCT03525106?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03525106 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic Cell Transplantation Recipient
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
RECRUITING
-
Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
ACTIVE NOT RECRUITING · Phase 2
-
Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant
COMPLETED · Phase 2
-
Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.